TCG Crossover Management, LLC Q4 2023 Filing

Filed February 14, 2024

Portfolio Value

$901.7B

Holdings

29

Report Date

Q4 2023

Filing Type

13F-HR

All Holdings (29 positions)

#StockSharesValue% PortfolioType
1
GPCRSTRUCTURE THERAPEUTICS INC
2,109,584$85K0.00%
2
INBXUSDINHIBRX,INC
1,750,387$66K0.00%
3
—ICOSAVAX INC
3,703,704$58K0.00%
4
—RAYZEBIO, INC.
869,908$54K0.00%
5
ANTXAN2 Therapeutics, Inc.
2,678,209$54K0.00%
6
GONGERON CORP
23,375,839$49K0.00%
7
AVTEAEROVATE THERAPEUTICS INC
2,201,274$49K0.00%
8
YB4PSAVARA INC.
10,000,000$47K0.00%
9
GRCLGRACELL BIOTECHNOLOGIES INC.
4,514,786$45K0.00%
10
MDGLMADRIGAL PHARMACEUTICALS INC
179,917$41K0.00%
11
KALVKALVISTA PHARMACEUTICALS, INC
3,395,495$41K0.00%
12
SLNSILENCE THERAPEUTICS PLC
2,104,875$36K0.00%
13
CMPSCOMPASS PATHWAYS PLC
3,858,000$33K0.00%
14
COGTCOGENT BIOSCIENCES INC
5,631,042$33K0.00%
15
TYRATYRA BIOSCIENCES INC
1,989,103$27K0.00%
16
TRMLTOURMALINE BIO INC
1,007,902$26K0.00%
17
TARSTARSUS PHARMACEUTICALS, INC.
1,142,857$23K0.00%
18
DYNDYNE THERAPEUTICS, INC
1,650,150$21K0.00%
19
KURAKURA ONCOLOGY INC
1,423,642$20K0.00%
20
CNTACENTESSA PHARMACEUTICALS PLC
2,040,816$16K0.00%
21
VTGNUSDVISTAGEN THERAPEUTICS INC
2,676,580$13K0.00%
22
CABACABALETTA BIO, INC
486,795$11K0.00%
23
ABVXAbivax SA
1,100,000$11K0.00%
24
TRDAENTRADA THERAPEUTICS INC
584,955$8K0.00%
25
NRIXNURIX THERAPEUTICS INC
717,654$7K0.00%
26
CCCCC4 THERAPEUTICS, INC.
1,276,574$7K0.00%
27
TSHATAYSHA GENE THERAPIES, INC.
2,912,861$5K0.00%
28
VTYXVENTYX BIOSCIENCES, INC
815,724$2K0.00%
29
KODKODIAK SCIENCES INC
267,941$00.00%